{"id":"https://openalex.org/W2966425610","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.10562","title":"Investigation of tumor biomarkers as response predictors in a monotherapy study with lapatinib (L) as a first line treatment in ErbB2 amplified women with breast cancer","display_name":"Investigation of tumor biomarkers as response predictors in a monotherapy study with lapatinib (L) as a first line treatment in ErbB2 amplified women with breast cancer","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2966425610","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.10562","mag":"2966425610"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.10562","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.10562","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.10562","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049679970","display_name":"Henry G\u00f3mez","orcid":"https://orcid.org/0000-0002-3415-9701","observed_orcids":["https://orcid.org/0000-0002-3415-9701","https://orcid.org/0000-0003-2660-1843"]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"H. L. Gomez","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072380607","display_name":"Miguel A. Chavez","orcid":"https://orcid.org/0000-0003-0561-6755","observed_orcids":["https://orcid.org/0000-0003-0561-6755"]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"M. A. Chavez","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085996586","display_name":"Dinesh Chandra Doval","orcid":"https://orcid.org/0000-0002-6191-563X","observed_orcids":["https://orcid.org/0000-0002-6191-563X"]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"D. C. Doval","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Franco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"S. Franco","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026406867","display_name":"Michael C. Arbushites","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"M. Arbushites","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113530937","display_name":"M. S. Berger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"M. S. Berger","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016117608","display_name":"Michelle Casey","orcid":"https://orcid.org/0000-0002-2821-6861","observed_orcids":["https://orcid.org/0000-0002-2821-6861"]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"M. A. Casey","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111885311","display_name":"S. Stein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"S. Stein","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088917458","display_name":"Tal Z. Zaks","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"T. Zaks","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103691008","display_name":"Adri\u00e1n Mart\u00edn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210092995","display_name":"Rajiv Gandhi Cancer Institute and Research Centre","ror":"https://ror.org/00e7cvg05","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210092995"]},{"id":"https://openalex.org/I4210123325","display_name":"Instituto Nacional de Enfermedades Neopl\u00e1sicas","ror":"https://ror.org/03674y156","country_code":"PE","type":"healthcare","lineage":["https://openalex.org/I4210123325"]}],"countries":["IN","PE"],"is_corresponding":false,"raw_author_name":"A. M. Martin","raw_affiliation_strings":["Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituto Nacional De Enfermedades Neoplasicas, Lima, Peru; Oncology Hospital Alberto Sabogal, Lima, Peru; Rajiv Gandhi Cancer Institute and Research Center, New Delhi, India; Memorial Cancer Institute, Hollywood, FL; GlaxoSmithKline, Collegeville, PA","institution_ids":["https://openalex.org/I4210092995","https://openalex.org/I4210123325"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"10562","last_page":"10562"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":1.0},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8920000195503235},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5230000019073486},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7760000228881836},{"id":"https://openalex.org/keywords/first-line-monotherapy","display_name":"first-line monotherapy","score":0.7170000076293945},{"id":"https://openalex.org/keywords/decision-tree-analysis","display_name":"decision tree analysis","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8902485370635986},{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.8828102350234985},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.7747489809989929},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5729302167892456},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.568073034286499},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5552381277084351},{"id":"https://openalex.org/C143660080","wikidata":"https://www.wikidata.org/wiki/Q7684883","display_name":"TaqMan","level":4,"score":0.49270275235176086},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4709761142730713},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4601519703865051},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44914889335632324},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.43269792199134827},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3396449685096741},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.32688093185424805},{"id":"https://openalex.org/C48023723","wikidata":"https://www.wikidata.org/wiki/Q856198","display_name":"Real-time polymerase chain reaction","level":3,"score":0.2589651048183441},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.21323230862617493},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.14360636472702026},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.13827747106552124},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.0944128930568695},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08727675676345825},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.10562","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.10562","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.10562","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2232313749","https://openalex.org/W1978947855","https://openalex.org/W2253789023","https://openalex.org/W2324278934","https://openalex.org/W2805969051","https://openalex.org/W2133857472","https://openalex.org/W2520982365","https://openalex.org/W2538582140","https://openalex.org/W2153457729","https://openalex.org/W2044099597"],"abstract_inverted_index":{"10562":[0],"Background:":[1],"Lapatinib":[2],"is":[3,217,270],"a":[4,175,207,238,256],"potent":[5],"inhibitor":[6],"of":[7,16,34,55,96,122,161,186,260,264,279],"both":[8,246],"EGFR":[9],"and":[10,66,100,174,214,228,245,248],"HER2":[11],"tyrosine":[12],"kinase":[13],"activity.":[14],"Results":[15],"the":[17,94,144,153,187,261],"phase":[18],"II":[19],"trial":[20],"EGF20009":[21],"in":[22,44,190,230,250,272],"advanced":[23],"or":[24,82],"metastatic":[25],"breast":[26],"cancer":[27],"(MBC)":[28],"indicated":[29],"an":[30,48,159,273],"overall":[31],"response":[32,68,80,84,168],"rate":[33,73],"24%":[35],"to":[36,50,69,142,169,178,204,275,288],"monotherapy":[37],"L":[38,172,183,205,254],"as":[39,77,127,129,255],"first":[40],"line":[41],"(1L)":[42],"treatment":[43,170,181],"138":[45],"patients.":[46],"In":[47],"effort":[49,274],"better":[51],"define":[52],"predictive":[53,278],"biomarkers":[54,277],"response,":[56],"we":[57],"evaluated":[58,119],"correlations":[59],"between":[60,240],"baseline":[61],"tumor":[62],"biomarker":[63],"expression":[64,121,163,209],"levels":[65,244],"clinical":[67,280],"L.":[70],"Methods:":[71],"Response":[72],"(RR)":[74],"was":[75,102,140,164,223],"defined":[76],"either":[78],"complete":[79],"(CR)":[81],"partial":[83],"(PR).":[85],"Tumor":[86],"blocks":[87,108],"were":[88,118],"available":[89],"on":[90],"118":[91],"patients":[92,251],"from":[93,104],"time":[95,177],"most":[97,146],"recent":[98],"biopsy,":[99],"mRNA":[101,243],"extracted":[103],"65":[105,155],"individual":[106],"patient":[107,156],"for":[109,120,133],"this":[110,191,231],"preliminary":[111,192,232],"analysis.":[112,233],"Using":[113],"qRT-PCR":[114],"Taqman":[115],"analysis,":[116],"tumors":[117],"ERBB1-":[123],"4,":[124],"PTEN,":[125],"c-MYC,":[126],"well":[128],"two":[130],"comparator":[131],"genes":[132,145],"normalization.":[134],"DecisionTree":[135],"analysis":[136,236],"using":[137],"SpotFire":[138,194],"software":[139],"performed":[141],"determine":[143,276],"significantly":[147,165],"associated":[148,166],"with":[149,167,171,182,225,253],"RR.":[150],"Results:":[151],"For":[152],"initial":[154],"samples":[157,265],"analyzed,":[158],"elevation":[160],"ERBB2":[162,242],"(p=0.02)":[173],"longer":[176],"progression":[179],"following":[180],"(p<0.0025).":[184],"Furthermore,":[185],"17/65":[188],"responders":[189],"study,":[193],"Decision":[195],"Tree":[196],"Analysis":[197,259],"demonstrated":[198],"that":[199],"16/17":[200],"(94%)":[201],"who":[202],"responded":[203],"had":[206],"gene":[208],"signature":[210],"combining":[211],"ERBB1,":[212],"2,":[213],"3,":[215],"which":[216],"currently":[218],"being":[219],"confirmed.":[220],"No":[221,284],"association":[222],"observed":[224],"ERBB4,":[226],"PTEN":[227],"c-MYC":[229],"Conclusion:":[234],"This":[235],"suggests":[237],"correlation":[239],"elevated":[241],"RR":[247],"TTP":[249],"treated":[252],"1L":[257],"treatment.":[258],"full":[262],"set":[263],"(including":[266],"genome-wide":[267],"microarray":[268],"analysis)":[269],"ongoing":[271],"activity":[281],"beyond":[282],"HER2.":[283],"significant":[285],"financial":[286],"relationships":[287],"disclose.":[289]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2019-08-13T00:00:00"}